Opportunity
Simpler Grants.gov #PAR-27-072
NIH Bioengineering Research Grants (BRG) Funding Opportunity for Multidisciplinary Biomedical Research
Buyer
National Institutes of Health
Posted
October 04, 2023
Respond By
February 05, 2026
Identifier
PAR-27-072
NAICS
541715, 541714, 541330
The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is seeking applications for Bioengineering Research Grants (BRG) to foster multidisciplinary collaborations addressing biomedical challenges with bioengineering solutions. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - OEMs and Vendors: - No specific Original Equipment Manufacturers (OEMs) or vendors are named, as this is a research grant opportunity rather than a procurement of specific products. - Products/Services Requested: - Multidisciplinary bioengineering research projects - Focus on integrating, optimizing, validating, translating, or accelerating adoption of innovative tools, methods, and techniques for biomedical research or clinical applications - No part numbers or specific product quantities are specified - Unique or Notable Requirements: - Encourages collaboration between life and physical sciences - Open to a wide range of applicants, including government, nonprofit, business, and educational organizations - No cost sharing or matching requirement - Discretionary health-related funding activity - Supports both basic and clinical science research - Place of Performance: - National Institutes of Health (NIH)
Description
This Notice of Funding Opportunity (NOFO) encourages collaborations between life and physical sciences to apply multidisciplinary bioengineering approaches to biomedical problems. The goal is to integrate, optimize, validate, translate, or accelerate the adoption of promising tools, methods, and techniques for specific research or clinical problems in basic, translational, or clinical science and practice. Applications may propose design-directed, developmental, discovery-driven, or hypothesis-driven research suitable for small teams using an integrative approach to solve problems in biological, clinical, or translational science.